Zealand and Generate sign up to $1.2bn obesity-drug deal

Zealand Pharma and Generate Biomedicines agreed an AI-led obesity-drug partnership worth up to $1.2bn. Generate will lead research, while Zealand will handle trials, approvals and global sales.